Thyroid Diseases
Welcome,         Profile    Billing    Logout  
 62 Companies   89 Products   89 Products   76 Mechanisms of Action   2 Trials   652 News 


«12...234567891011121314»
  • ||||||||||  Caprelsa (vandetanib) / Sanofi
    Enrollment closed:  Vandetanib Risk Minimisation Effectiveness (clinicaltrials.gov) -  Jul 30, 2013   
    P=N/A,  N=20, Active, not recruiting, 
    N=200 --> 153 Recruiting --> Active, not recruiting
  • ||||||||||  pentoxifylline / Generic mfg., bromocriptine / Generic mfg.
    Trial termination:  Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment (clinicaltrials.gov) -  Jul 1, 2013   
    P=N/A,  N=31, Terminated, 
    Recruiting --> Active, not recruiting Not yet recruiting --> Terminated; Efficacy demonstrated on a preliminary analysis
  • ||||||||||  temozolomide / Generic mfg., capecitabine / Generic mfg.
    Enrollment change, Metastases:  Capecitabine and Temozolomide for Neuroendocrine Cancers (clinicaltrials.gov) -  Jun 30, 2013   
    P2,  N=38, Active, not recruiting, 
    Not yet recruiting --> Terminated; Efficacy demonstrated on a preliminary analysis N=29 --> 38
  • ||||||||||  Enrollment closed:  LL-PTC: Leptin Levels in Papillary Thyroid Cancer (clinicaltrials.gov) -  Jun 16, 2013   
    P=N/A,  N=150, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting
  • ||||||||||  Trial completion:  Iodine I 131 in Treating Patients With Thyroid Cancer (clinicaltrials.gov) -  May 14, 2013   
    P=N/A,  N=9, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed
  • ||||||||||  New P4 trial:  The TRUST Study - Depression Substudy (clinicaltrials.gov) -  May 13, 2013   
    P4,  N=1500, Recruiting, 
  • ||||||||||  Enrollment closed, IO biomarker:  Autoimmune Thyroid Disease Genetic Study (clinicaltrials.gov) -  Apr 8, 2013   
    P=N/A,  N=4000, Active, not recruiting, 
    Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Enrollment change:  Central Hypothyroidism and Cardiovascular Risk (clinicaltrials.gov) -  Mar 29, 2013   
    P=N/A,  N=200, Completed, 
    Suspended --> Active, not recruiting N=300 --> 200